GE Healthcare News

1. Cytiva And Multiply Labs Collaborate To Automate Cell Therapy Manufacturing 5/26/2021

   Cytiva, a global life sciences leader, and Multiply Labs, a leader in developing robotic systems for pharmaceutical manufacturing, are collaborating to develop a robotic manufacturing system that will automate the manual portions of the cell therapy manufacturing workflow. Creating a fully automated system that can operate at an industrial scale will enable the speed and flexibility that is needed to manufacture these next generation therapeutics.

2. Cytiva And Brooks Life Sciences To Enhance Automation In Cold Chain Solutions 2/16/2021

   Cytiva, a global life sciences leader, and Brooks Life Sciences, a division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to seamlessly integrate Brooks Life Sciences BioStore III automated storage platform, which is purpose built to handle a wide range of high value materials between the temperatures of -20°C and -190°C in an efficient, documented way. Chronicle software will provide a unified digital platform that can electronically trace cellular products and raw materials through the cell therapy workflow including the cryogenic cold chain.

3. G-CON Manufacturing And GE Healthcare Announce Collaboration To Advance Early-Stage Cell Therapy And Viral Vector Manufacturing 1/21/2019

   G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions (“PODs”) and GE Healthcare plan to collaborate to improve cell therapy and viral vector manufacturing by providing drug developers with a combined, flexible, and readily deployable manufacturing platform suitable for early-stage clinical or commercial production.

4. Scaling Up Cell Therapy Manufacturing In Guangzhou 9/4/2018

   GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T Cell Immunotherapy Drugs.

5. GE Healthcare Life Sciences Opens Cell And Gene Therapy Asia Technology Center In Shanghai 8/31/2018

   Building GE Healthcare's first cell and gene therapy laboratory in Asia, the center aims to enable new developments and commercialization of precision medicine in Asia.